Alogliptin improves steroid-induced hyperglycemia in treatment-naïve Japanese patients with chronic kidney disease by decrease of plasma glucagon levels

BACKGROUND: Chronic kidney disease (CKD) is a risk factor for end-stage renal failure and cardiovascular disease, and a strategy to counteract CKD must be established. CKD caused by immunological abnormalities is treated by steroids, frequently resulting in steroid diabetes. Although insulin is the...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Ohashi, Naro, Tsuji, Naoko, Naito, Yoshitaka, Iwakura, Takamasa, Isobe, Shinsuke, Ono, Masafumi, Fujikura, Tomoyuki, Tsuji, Takayuki, Sakao, Yukitoshi, Yasuda, Hideo, Kato, Akihiko, Fujigaki, Yoshihide
Format: Artigo
Idioma:Inglês
Publicat: International Scientific Literature, Inc. 2014
Matèries:
Clinical Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3989946/
https://ncbi.nlm.nih.gov/pubmed/24717767
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.889872
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars